{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:23:10Z","timestamp":1791937390686,"version":"4.3.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010905","name":"Major Research Plan","doi-asserted-by":"publisher","award":["91849111"],"award-info":[{"award-number":["91849111"]}],"id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770253; 81370362; 81670214"],"award-info":[{"award-number":["81770253; 81370362; 81670214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10741-020-09957-5","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T12:03:02Z","timestamp":1587384182000},"page":"1249-1258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The Elabela-APJ axis: a promising therapeutic target for heart failure"],"prefix":"10.1007","volume":"26","author":[{"given":"Zheng","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Juan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiu-Chang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"issue":"10","key":"9957_CR1","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1161\/CIRCRESAHA.116.307475","volume":"118","author":"I Alfaras","year":"2016","unstructured":"Alfaras I, Di Germanio C, Bernier M, Csiszar A, Ungvari Z, Lakatta EG, de Cabo R (2016) Pharmacological strategies to retard cardiovascular aging. Circ Res 118(10):1626\u20131642","journal-title":"Circ Res"},{"issue":"1","key":"9957_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ccl.2007.10.005","volume":"26","author":"LW Miller","year":"2008","unstructured":"Miller LW (2008) Heart failure: who we treat versus who we study. Cardiol Clin 26(1):113\u2013125","journal-title":"Cardiol Clin"},{"issue":"11","key":"9957_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMp1410241","volume":"371","author":"CA Sacks","year":"2014","unstructured":"Sacks CA, Jarcho JA, Curfman GD (2014) Paradigm shifts in heart-failure therapy \u2014 a timeline. New Engl J Med 371(11):989\u2013991","journal-title":"New Engl J Med"},{"issue":"4","key":"9957_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1124\/pr.119.017533","volume":"71","author":"C Read","year":"2019","unstructured":"Read C, Nyimanu D, Williams TL, Huggins DJ, Sulentic P, Macrae RGC, Yang P, Glen RC, Maguire JJ, Davenport AP (2019) International Union of Basic and Clinical Pharmacology. CVII. Structure and pharmacology of the apelin receptor with a recommendation that Elabela\/Toddler is a second endogenous peptide ligand. Pharmacol Rev 71(4):467\u2013502","journal-title":"Pharmacol Rev"},{"issue":"2","key":"9957_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","volume":"251","author":"K Tatemoto","year":"1998","unstructured":"Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX et al (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251(2):471\u2013476","journal-title":"Biochem Biophys Res Commun"},{"key":"9957_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41371-019-0163-5","volume":"33","author":"C Ureche","year":"2019","unstructured":"Ureche C, Tapoi L, Volovat S, Voroneanu L, Kanbay M, Covic A (2019) Cardioprotective apelin effects and the cardiac-renal axis: review of existing science and potential therapeutic applications of synthetic and native regulated apelin. J Hum Hypertens 33:429\u2013435. https:\/\/doi.org\/10.1038\/s41371-019-0163-5","journal-title":"J Hum Hypertens"},{"issue":"4","key":"9957_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10741-015-9475-x","volume":"20","author":"A Folino","year":"2015","unstructured":"Folino A, Montarolo PG, Samaja M, Rastaldo R (2015) Effects of apelin on the cardiovascular system. Heart Fail Rev 20(4):505\u2013518","journal-title":"Heart Fail Rev"},{"issue":"2","key":"9957_CR8","doi-asserted-by":"publisher","first-page":"e12924","DOI":"10.1111\/apha.12924","volume":"222","author":"A Folino","year":"2018","unstructured":"Folino A, Accomasso L, Giachino C, Montarolo PG, Losano G, Pagliaro P, Rastaldo R (2018) Apelin-induced cardioprotection against ischaemia\/reperfusion injury: roles of epidermal growth factor and Src. Acta Physiol 222(2):e12924","journal-title":"Acta Physiol"},{"issue":"6","key":"9957_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","volume":"27","author":"SC Chng","year":"2013","unstructured":"Chng SC, Ho L, Tian J, Reversade B (2013) ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 27(6):672\u2013680","journal-title":"Dev Cell"},{"issue":"6172","key":"9957_CR10","doi-asserted-by":"publisher","first-page":"1248636","DOI":"10.1126\/science.1248636","volume":"343","author":"A Pauli","year":"2014","unstructured":"Pauli A, Norris ML, Valen E, Chew GL, Gagnon JA, Zimmerman S, Mitchell A, Ma J, Dubrulle J, Reyon D, Tsai SQ, Joung JK, Saghatelian A, Schier AF (2014) Toddler: an embryonic signal that promotes cell movement via apelin receptors. Science 343(6172):1248636\u20131248636","journal-title":"Science"},{"issue":"2\u20133","key":"9957_CR11","first-page":"162","volume":"1538","author":"Y Kawamata","year":"2001","unstructured":"Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S et al (2001) Molecular properties of apelin: tissue distribution and receptor binding. BBA-Mol Cell Res 1538(2\u20133):162\u2013171","journal-title":"BBA-Mol Cell Res"},{"key":"9957_CR12","doi-asserted-by":"publisher","unstructured":"Wang Z, Yu D, Wang M, Wang Q, Kouznetsova J, Yang R et al (2015) Elabela-apelin receptor signaling pathway is functional in mammalian systems. Sci Rep. https:\/\/doi.org\/10.1038\/srep08170","DOI":"10.1038\/srep08170"},{"issue":"12","key":"9957_CR13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","volume":"135","author":"P Yang","year":"2017","unstructured":"Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R et al (2017) Elabela\/toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation 135(12):1160\u20131173","journal-title":"Circulation"},{"issue":"7","key":"9957_CR14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/cvr\/cvx061","volume":"113","author":"T Sato","year":"2017","unstructured":"Sato T, Sato C, Kadowaki A, Watanabe H, Ho L, Ishida J, Yamaguchi T, Kimura A, Fukamizu A, Penninger JM, Reversade B, Ito H, Imai Y, Kuba K (2017) ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage. Cardiovasc Res 113(7):760\u2013769","journal-title":"Cardiovasc Res"},{"issue":"1","key":"9957_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-015-0521-6","volume":"111","author":"\u00c1 Perj\u00e9s","year":"2016","unstructured":"Perj\u00e9s \u00c1, Kilpi\u00f6 T, Ulvila J, Magga J, Alakoski T, Szab\u00f3 Z et al (2016) Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart. Basic Res Cardiol 111(1):2. https:\/\/doi.org\/10.1007\/s00395-015-0521-6","journal-title":"Basic Res Cardiol"},{"issue":"11","key":"9957_CR16","doi-asserted-by":"publisher","first-page":"e1139","DOI":"10.1097\/CCM.0000000000002639","volume":"45","author":"D Coquerel","year":"2017","unstructured":"Coquerel D, Chagnon F, Sainsily X, Dumont L, Murza A, C\u00f4t\u00e9 J, Dumaine R, Sarret P, Marsault \u00c9, Salvail D, Auger-Messier M, Lesur O (2017) Elabela improves cardio-renal outcome in fatal experimental septic shock. Crit Care Med 45(11):e1139\u2013e1148","journal-title":"Crit Care Med"},{"issue":"7","key":"9957_CR17","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1021\/acs.jmedchem.5b01549","volume":"59","author":"A Murza","year":"2016","unstructured":"Murza A, Sainsily X, Coquerel D, C\u00f4t\u00e9 J, Marx P, Besserer-Offroy \u00c9, Longpr\u00e9 JM, Lain\u00e9 J, Reversade B, Salvail D, Leduc R, Dumaine R, Lesur O, Auger-Messier M, Sarret P, Marsault \u00c9 (2016) Discovery and structure\u2013activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions. J Med Chem 59(7):2962\u20132972","journal-title":"J Med Chem"},{"issue":"9","key":"9957_CR18","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1681\/ASN.2016111210","volume":"28","author":"H Chen","year":"2017","unstructured":"Chen H, Wang L, Wang W, Cheng C, Zhang Y, Zhou Y, Wang C, Miao X, Wang J, Wang C, Li J, Zheng L, Huang K (2017) ELABELA and an ELABELA fragment protect against AKI. J Am Soc Nephrol 28(9):2694\u20132707","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"9957_CR19","first-page":"399","volume":"24","author":"CM Goidescu","year":"2016","unstructured":"Goidescu CM, Anton FP, Leucu\u021ba DC, Mircea PA, Vida-Simiti LA (2016) Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients. Rev Romana Med Lab 24(4):399\u2013412","journal-title":"Rev Romana Med Lab"},{"issue":"8","key":"9957_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002922","volume":"9","author":"WL Miller","year":"2016","unstructured":"Miller WL (2016) Fluid volume overload and congestion in heart failure: time to reconsider pathophysiology and how volume is assessed. Circ Heart Fail 9(8):e002922","journal-title":"Circ Heart Fail"},{"issue":"4","key":"9957_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000337104","volume":"33","author":"V Cernaro","year":"2012","unstructured":"Cernaro V, Lacquaniti A, Lorenzano G, Loddo S, Romeo A, Donato V et al (2012) Apelin, plasmatic osmolality and hypotension in dialyzed patients. Blood Purif 33(4):317\u2013323","journal-title":"Blood Purif"},{"issue":"30","key":"9957_CR22","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1074\/jbc.M115.648238","volume":"290","author":"C Deng","year":"2015","unstructured":"Deng C, Chen H, Yang N, Feng Y, Hsueh AJW (2015) Apela regulates fluid homeostasis by binding to the APJ receptor to activate Gi signaling. J Biol Chem 290(30):18261\u201318268","journal-title":"J Biol Chem"},{"issue":"1","key":"9957_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2741\/3923","volume":"17","author":"L Jia","year":"2012","unstructured":"Jia L, Li Y, Xiao C, Du J (2012) Angiotensin II induces inflammation leading to cardiac remodeling. Front Biosci 17(1):221\u2013231","journal-title":"Front Biosci"},{"issue":"5\u20136","key":"9957_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10557-017-6752-z","volume":"31","author":"KF Ayoub","year":"2017","unstructured":"Ayoub KF, Pothineni NVK, Rutland J, Ding Z, Mehta JL (2017) Immunity, inflammation, and oxidative stress in heart failure: emerging molecular targets. Cardiovasc Drug Ther 31(5\u20136):593\u2013608","journal-title":"Cardiovasc Drug Ther"},{"key":"9957_CR25","doi-asserted-by":"publisher","unstructured":"Xi Y, Yu D, Yang R, Zhao Q, Wang J, Zhang H et al (2019) Recombinant Elabela-Fc fusion protein has extended plasma half-life and mitigates post-infarct heart dysfunction in rats. Int J Cardiol. https:\/\/doi.org\/10.1016\/j.ijcard.2019.04.089","DOI":"10.1016\/j.ijcard.2019.04.089"},{"issue":"6","key":"9957_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.devcel.2017.08.008","volume":"42","author":"B Sharma","year":"2017","unstructured":"Sharma B, Ho L, Ford GH, Chen HI, Goldstone AB, Woo YJ et al (2017) Alternative progenitor cells compensate to rebuild the coronary vasculature in Elabela- and APJ-deficient hearts. Dev Cell 42(6):655\u2013666.e3","journal-title":"Dev Cell"},{"issue":"4","key":"9957_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.stem.2015.08.010","volume":"17","author":"L Ho","year":"2015","unstructured":"Ho L, Tan SYX, Wee S, Wu Y, Tan SJC, Ramakrishna NB, Chng SC, Nama S, Szczerbinska I, Chan YS, Avery S, Tsuneyoshi N, Ng HH, Gunaratne J, Dunn NR, Reversade B (2015) ELABELA is an endogenous growth factor that sustains hESC self-renewal via the PI3K\/AKT pathway. Cell Stem Cell 17(4):435\u2013447","journal-title":"Cell Stem Cell"},{"key":"9957_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12010-019-03012-2","volume":"189","author":"Z Wang","year":"2019","unstructured":"Wang Z, Huang J (2019) Apela promotes cardiomyocyte differentiation from transgenic human embryonic stem cell lines. Appl Biochem Biotechnol 189:396\u2013410. https:\/\/doi.org\/10.1007\/s12010-019-03012-2","journal-title":"Appl Biochem Biotechnol"},{"issue":"1","key":"9957_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/cphy.c170028","volume":"8","author":"K Shin","year":"2017","unstructured":"Shin K, Kenward C, Rainey JK (2017) Apelinergic system structure and function. Compr Physiol 8(1):407\u2013450","journal-title":"Compr Physiol"},{"issue":"11","key":"9957_CR30","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/abbs\/gmx098","volume":"49","author":"L Li","year":"2017","unstructured":"Li L, Zhou Q, Li X, Chen L (2017) Elabela-APJ axis: a novel therapy target for cardiovascular diseases. Acta Biochim Biophys Sin 49(11):1042\u20131043","journal-title":"Acta Biochim Biophys Sin"},{"issue":"5","key":"9957_CR31","doi-asserted-by":"publisher","first-page":"H1904","DOI":"10.1152\/ajpheart.00686.2009","volume":"297","author":"DN Charo","year":"2009","unstructured":"Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY et al (2009) Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol-Heart C 297(5):H1904\u2013H1913","journal-title":"Am J Physiol-Heart C"},{"issue":"8","key":"9957_CR32","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.bbadis.2016.11.007","volume":"1863","author":"JC Zhong","year":"2017","unstructured":"Zhong JC, Zhang ZZ, Wang W, McKinnie SMK, Vederas JC, Oudit GY (2017) Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases. BBA-Mol Basis Dis 1863(8):1942\u20131950","journal-title":"BBA-Mol Basis Dis"},{"issue":"6","key":"9957_CR33","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1007\/s00246-018-1879-7","volume":"39","author":"D El Amrousy","year":"2018","unstructured":"El Amrousy D, El-Mahdy H (2018) Prognostic value of serum apelin level in children with heart failure secondary to congenital heart disease. Pediatr Cardiol 39(6):1188\u20131193","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"9957_CR34","first-page":"690","volume":"32","author":"M Topuz","year":"2016","unstructured":"Topuz M, Cosgun M, Akku\u015f O, Bulut A, Sen O, Topuz AN, Cayl\u0131 M (2016) Effect of spironolactone on plasma apelin-12 levels in patients with chronic systolic heart failure. Acta Cardiol Sin 32(6):690\u2013697","journal-title":"Acta Cardiol Sin"},{"issue":"2","key":"9957_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000092122","volume":"26","author":"J Ma\u0142yszko","year":"2006","unstructured":"Ma\u0142yszko J, Ma\u0142yszko JS, Ko\u017aminski P, My\u015bliwiec M (2006) Apelin and cardiac function in hemodialyzed patients: possible relations? Am J Nephrol 26(2):121\u2013126","journal-title":"Am J Nephrol"},{"issue":"5","key":"9957_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/HJH.0b013e328344da76","volume":"29","author":"M Przewlocka-Kosmala","year":"2011","unstructured":"Przewlocka-Kosmala M, Kotwica T, Mysiak A, Kosmala W (2011) Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction. J Hypertens 29(5):971\u2013979","journal-title":"J Hypertens"},{"issue":"7","key":"9957_CR37","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cardfail.2010.02.004","volume":"16","author":"B Chandrasekaran","year":"2010","unstructured":"Chandrasekaran B, Kalra PR, Donovan J, Hooper J, Clague JR, McDonagh TA (2010) Myocardial apelin production is reduced in humans with left ventricular systolic dysfunction. J Card Fail 16(7):556\u2013561","journal-title":"J Card Fail"},{"issue":"6","key":"9957_CR38","doi-asserted-by":"publisher","first-page":"E1218","DOI":"10.1152\/ajpendo.00257.2019","volume":"317","author":"D Georgiadou","year":"2019","unstructured":"Georgiadou D, Boussata S, van Dijk M (2019) ELABELA measurements by commercial ELISA kits require sample extraction. Am J Physiol Endocrinol Metab 317(6):E1218\u2013E1219","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"9957_CR39","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tips.2015.06.002","volume":"36","author":"P Yang","year":"2015","unstructured":"Yang P, Maguire JJ, Davenport AP (2015) Apelin, Elabela\/toddler, and biased agonists as novel therapeutic agents in the cardiovascular system. Trends Pharmacol Sci 36(9):560\u2013567","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"9957_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3892\/ijmm.2014.1829","volume":"34","author":"H Pang","year":"2014","unstructured":"Pang H, Han B, Yu T, Zong Z (2014) Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure. Int J Mol Med 34(3):756\u2013764","journal-title":"Int J Mol Med"},{"issue":"1","key":"9957_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1253\/circj.CJ-11-0689","volume":"76","author":"W Koguchi","year":"2012","unstructured":"Koguchi W, Kobayashi N, Takeshima H, Ishikawa M, Sugiyama F, Ishimitsu T (2012) Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure. Circ J 76(1):137\u2013144","journal-title":"Circ J"},{"issue":"9","key":"9957_CR42","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1016\/j.cardfail.2011.06.590","volume":"17","author":"N Kobayashi","year":"2011","unstructured":"Kobayashi N, Takeshima H, Koguchi W, Ishikawa M, Sugiyama F, Mamada Y et al (2011) Cardioprotective effect of apelin-13 on cardiac performance and remodeling in Dahl rats with end-stage heart failure. J Card Fail 17(9):S171","journal-title":"J Card Fail"},{"issue":"4","key":"9957_CR43","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1097\/CCM.0000000000002097","volume":"45","author":"F Chagnon","year":"2017","unstructured":"Chagnon F, Coquerel D, Salvail D, Marsault E, Dumaine R, Auger-messier M et al (2017) Apelin compared with dobutamine exerts cardioprotection and extends survival in a rat model of endotoxin-induced myocardial dysfunction. Crit Care Med 45(4):e391\u2013e398","journal-title":"Crit Care Med"},{"issue":"6","key":"9957_CR44","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/0735-1097(94)90390-5","volume":"23","author":"G de Simone","year":"1994","unstructured":"de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH (1994) Assessment of left ventricular function by the mid-wall fractional shortening\/end-systolic stress relation in human hypertension. J Am Coll Cardiol 23(6):1444\u20131451","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"9957_CR45","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Phys 292(1):C82\u2013C97","journal-title":"Am J Physiol Cell Phys"},{"issue":"1","key":"9957_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","volume":"74","author":"DK Lee","year":"2001","unstructured":"Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y et al (2001) Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74(1):34\u201341","journal-title":"J Neurochem"},{"issue":"25","key":"9957_CR47","doi-asserted-by":"publisher","first-page":"26274","DOI":"10.1074\/jbc.M404149200","volume":"279","author":"J Ishida","year":"2004","unstructured":"Ishida J, Hashimoto T, Hashimoto Y, Nishiwaki S, Iguchi T, Harada S, Sugaya T, Matsuzaki H, Yamamoto R, Shiota N, Okunishi H, Kihara M, Umemura S, Sugiyama F, Yagami K, Kasuya Y, Mochizuki N, Fukamizu A (2004) Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 279(25):26274\u201326279","journal-title":"J Biol Chem"},{"key":"9957_CR48","first-page":"1","volume":"22","author":"Y Li","year":"2019","unstructured":"Li Y, Yang X, Ouyang S, He J, Yu B, Lin X et al (2019) Declined circulating Elabela levels in patients with essential hypertension and its association with impaired vascular function: a preliminary study. Clin Exp Hypertens 22:1\u20135","journal-title":"Clin Exp Hypertens"},{"key":"9957_CR49","first-page":"1","volume":"7","author":"R Deniz","year":"2019","unstructured":"Deniz R, Baykus Y, Ustebay S, Ugur K, Yavuzkir \u015e, Aydin S (2019) Evaluation of elabela, apelin and nitric oxide findings in maternal blood of normal pregnant women, pregnant women with pre-eclampsia, severe pre-eclampsia and umbilical arteries and venules of newborns. J Obstet Gynaecol 7:1\u20136","journal-title":"J Obstet Gynaecol"},{"issue":"5","key":"9957_CR50","doi-asserted-by":"publisher","first-page":"E773","DOI":"10.1152\/ajpendo.00383.2018","volume":"316","author":"L Zhou","year":"2019","unstructured":"Zhou L, Sun H, Cheng R, Fan X, Lai S, Deng C (2019) ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ. Am J Physiol Endocrinol Metab 316(5):E773\u2013E781","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"9957_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ccl.2016.04.001","volume":"34","author":"KW Prins","year":"2016","unstructured":"Prins KW, Thenappan T (2016) World Health Organization Group I pulmonary hypertension. Cardiol Clin 34(3):363\u2013374","journal-title":"Cardiol Clin"},{"issue":"1\u20133","key":"9957_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.regpep.2005.09.032","volume":"133","author":"JP Goetze","year":"2006","unstructured":"Goetze JP, Rehfeld JF, Carlsen J, Videbaek R, Andersen CB, Boesgaard S, Friis-Hansen L (2006) Apelin: a new plasma marker of cardiopulmonary disease. Regul Pept 133(1\u20133):134\u2013138","journal-title":"Regul Pept"},{"issue":"4","key":"9957_CR53","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/ATVBAHA.110.219980","volume":"31","author":"SM Chandra","year":"2011","unstructured":"Chandra SM, Razavi H, Kim J, Agrawal R, Kundu RK, de Jesus PV et al (2011) Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension. Arterioscler Thromb Vasc Biol 31(4):814\u2013820","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9957_CR54","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijcard.2017.04.082","volume":"243","author":"Y Okuhara","year":"2017","unstructured":"Okuhara Y, Yokoe S, Iwasaku T, Eguchi A, Nishimura K, Li W, Oboshi M, Naito Y, Mano T, Asahi M, Okamura H, Masuyama T, Hirotani S (2017) Interleukin-18 gene deletion protects against sepsis-induced cardiac dysfunction by inhibiting PP2A activity. Int J Cardiol 243:396\u2013403","journal-title":"Int J Cardiol"},{"issue":"3","key":"9957_CR55","doi-asserted-by":"publisher","first-page":"254","DOI":"10.11613\/BM.2011.035","volume":"1","author":"D Gruson","year":"2011","unstructured":"Gruson D, Ahn SA, Rousseau MF (2011) Biomarkers of inflammation and cardiac remodeling: the quest of relevant companions for the risk stratification of heart failure patients is still ongoing. Biochem Med 1(3):254\u2013263","journal-title":"Biochem Med"},{"issue":"9453","key":"9957_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","volume":"365","author":"D Annane","year":"2005","unstructured":"Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365(9453):63\u201378","journal-title":"Lancet"},{"issue":"4","key":"9957_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11897-017-0343-y","volume":"14","author":"N Suthahar","year":"2017","unstructured":"Suthahar N, Meijers WC, Sillj\u00e9 HHW, de Boer RA (2017) From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities. Curr Heart Fail Rep 14(4):235\u2013250","journal-title":"Curr Heart Fail Rep"},{"key":"9957_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cca.2014.09.006","volume":"443","author":"C Passino","year":"2015","unstructured":"Passino C, Barison A, Vergaro G, Gabutti A, Borrelli C, Emdin M, Clerico A (2015) Markers of fibrosis, inflammation, and remodeling pathways in heart failure. Clin Chim Acta 443:29\u201338","journal-title":"Clin Chim Acta"},{"issue":"3","key":"9957_CR59","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ygyno.2017.10.016","volume":"147","author":"Y Yi","year":"2017","unstructured":"Yi Y, Tsai SH, Cheng JC, Wang EY, Anglesio MS, Cochrane DR, Fuller M, Gibb EA, Wei W, Huntsman DG, Karsan A, Hoodless PA (2017) APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner. Gynecol Oncol 147(3):663\u2013671","journal-title":"Gynecol Oncol"},{"issue":"17","key":"9957_CR60","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012826","volume":"8","author":"J Wang","year":"2019","unstructured":"Wang J, Wei L, Yang X, Zhong J (2019) Roles of growth differentiation factor 15 in atherosclerosis and coronary artery disease. J Am Heart Assoc 8(17):e012826","journal-title":"J Am Heart Assoc"},{"issue":"9457","key":"9957_CR61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0140-6736(05)70238-5","volume":"365","author":"N Lameire","year":"2005","unstructured":"Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365(9457):417\u2013430","journal-title":"Lancet"},{"issue":"5","key":"9957_CR62","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1566523217666161121111906","volume":"16","author":"CA Schreiber","year":"2017","unstructured":"Schreiber CA, Holditch SJ, Generous A, Ikeda Y (2017) Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats. Curr Gene Ther 16(5):349\u2013360","journal-title":"Curr Gene Ther"},{"key":"9957_CR63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.peptides.2019.04.005","volume":"114","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang Y, Luo M, Xu F, Lu Y, Zhou X, Cui W, Miao L (2019) Elabela protects against podocyte injury in mice with streptozocin-induced diabetes by associating with the PI3K\/Akt\/mTOR pathway. Peptides 114:29\u201337","journal-title":"Peptides"},{"issue":"3","key":"9957_CR64","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1159\/000492093","volume":"48","author":"H Zhang","year":"2018","unstructured":"Zhang H, Gong D, Ni L, Shi L, Xu W, Shi M, Chen J, Ai Y, Zhang X (2018) Serum Elabela\/toddler levels are associated with albuminuria in patients with type 2 diabetes. Cell Physiol Biochem 48(3):1347\u20131354","journal-title":"Cell Physiol Biochem"},{"issue":"6352","key":"9957_CR65","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1126\/science.aam6607","volume":"357","author":"L Ho","year":"2017","unstructured":"Ho L, van Dijk M, Chye STJ, Messerschmidt DM, Chng SC, Ong S, Yi LK, Boussata S, Goh GH, Afink GB, Lim CY, Dunn NR, Solter D, Knowles BB, Reversade B (2017) ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science 357(6352):707\u2013713","journal-title":"Science"},{"issue":"5","key":"9957_CR66","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2353\/ajpath.2008.070762","volume":"172","author":"V Koka","year":"2008","unstructured":"Koka V, Huang XR, Chung ACK, Wang W, Truong LD, Lan HY (2008) Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK\/p38 MAP kinase pathway. Am J Pathol 172(5):1174\u20131183","journal-title":"Am J Pathol"},{"issue":"8","key":"9957_CR67","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel VB, Zhong JC, Grant MB, Oudit GY (2016) Role of the ACE2\/angiotensin 1\u20137 axis of the renin\u2013angiotensin system in heart failure. Circ Res 118(8):1313\u20131326","journal-title":"Circ Res"},{"issue":"7","key":"9957_CR68","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","volume":"122","author":"J Zhong","year":"2010","unstructured":"Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY (2010) Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation 122(7):717\u2013728","journal-title":"Circulation"},{"key":"9957_CR69","doi-asserted-by":"publisher","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q (2020) Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. https:\/\/doi.org\/10.1126\/science.abb2762","DOI":"10.1126\/science.abb2762"},{"issue":"38","key":"9957_CR70","doi-asserted-by":"publisher","first-page":"E5628","DOI":"10.1073\/pnas.1525078113","volume":"113","author":"J Yang","year":"2016","unstructured":"Yang J, Feng X, Zhou Q, Cheng W, Shang C, Han P et al (2016) Pathological ACE2-to-ACE enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1\u2013FoxM1 complex. Proc Natl Acad Sci USA 113(38):E5628\u2013E5635","journal-title":"Proc Natl Acad Sci USA"},{"key":"9957_CR71","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.117.10156","volume":"70","author":"ZZ Zhang","year":"2017","unstructured":"Zhang ZZ, Wang W, Jin HY, Chen X, Cheng YW, Xu YL, Song B, Penninger JM, Oudit GY, Zhong JC (2017) Pyr-apelin-13 is a negative regulator of angiotensin II-mediated adverse myocardial remodeling and dysfunction. Hypertension 70:1165\u20131175","journal-title":"Hypertension"},{"issue":"6","key":"9957_CR72","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.peptides.2009.02.010","volume":"30","author":"XJ Zeng","year":"2009","unstructured":"Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ, Tang CS (2009) Apelin protects heart against ischemia\/reperfusion injury in rat. Peptides 30(6):1144\u20131152","journal-title":"Peptides"},{"key":"9957_CR73","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.aanat.2018.12.006","volume":"222","author":"S Bunbupha","year":"2019","unstructured":"Bunbupha S, Pakdeechote P, Maneesai P, Prachaney P, Boonprom P (2019) Carthamus Tinctorius L. extract attenuates cardiac remodeling in L-NAME-induced hypertensive rats by inhibiting the NADPH oxidase-mediated TGF-\u03b21 and MMP-9 pathway. Ann Anat 222:120\u2013128","journal-title":"Ann Anat"},{"issue":"5","key":"9957_CR74","doi-asserted-by":"publisher","first-page":"6263","DOI":"10.1002\/jcp.27357","volume":"234","author":"D Wu","year":"2019","unstructured":"Wu D, Huang D, Li LL, Ni P, Li XX, Wang B, Han YN, Shao XQ, Zhao D, Chu WF, Li BY (2019) TGF-\u03b21-PML SUMOylation-peptidyl- prolyl cis\u2013trans isomerase NIMA-interacting 1 (Pin1) form a positive feedback loop to regulate cardiac fibrosis. J Cell Physiol 234(5):6263\u20136273","journal-title":"J Cell Physiol"},{"issue":"16","key":"9957_CR75","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/CIRCULATIONAHA.109.911339","volume":"121","author":"AG Japp","year":"2010","unstructured":"Japp AG, Cruden NL, Barnes G, van Gemeren N, Mathews J, Adamson J, Johnston NR, Denvir MA, Megson IL, Flapan AD, Newby DE (2010) Acute cardiovascular effects of apelin in humans. Circulation 121(16):1818\u20131827","journal-title":"Circulation"},{"issue":"3","key":"9957_CR76","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cardiores.2007.02.002","volume":"74","author":"J Zhong","year":"2007","unstructured":"Zhong J, Yu X, Huang Y, Yung L, Lau C, Lin S (2007) Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res 74(3):388\u2013395","journal-title":"Cardiovasc Res"},{"issue":"1","key":"9957_CR77","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1210\/en.2004-0359","volume":"146","author":"DK Lee","year":"2005","unstructured":"Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR, O\u2019Dowd BF (2005) Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 146(1):231\u2013236","journal-title":"Endocrinology"},{"issue":"35","key":"9957_CR78","doi-asserted-by":"publisher","first-page":"24599","DOI":"10.1074\/jbc.M113.541698","volume":"289","author":"E Ceraudo","year":"2014","unstructured":"Ceraudo E, Galanth C, Carpentier E, Banegas-Font I, Schonegge AM, Alvear-Perez R, Iturrioz X, Bouvier M, Llorens-Cortes C (2014) Biased signaling favoring Gi over \u03b2-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine. J Biol Chem 289(35):24599\u201324610","journal-title":"J Biol Chem"},{"issue":"1","key":"9957_CR79","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/psc.2836","volume":"22","author":"R Behrendt","year":"2016","unstructured":"Behrendt R, White P, Offer J (2016) Advances in Fmoc solid-phase peptide synthesis. J Pept Sci 22(1):4\u201327","journal-title":"J Pept Sci"},{"issue":"5","key":"9957_CR80","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbamem.2017.01.028","volume":"1859","author":"SK Huang","year":"2017","unstructured":"Huang SK, Shin K, Sarker M, Rainey JK (2017) Apela exhibits isoform- and headgroup-dependent modulation of micelle binding, peptide conformation and dynamics. BBA-Biomembranes 1859(5):767\u2013778","journal-title":"BBA-Biomembranes"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-09957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-020-09957-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-09957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T02:03:25Z","timestamp":1744077805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-020-09957-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["9957"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-09957-5","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"assertion":[{"value":"20 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}